406 related articles for article (PubMed ID: 31433756)
1. TNF-α and IL-6: The Link between Immune and Bone System.
Wang T; He C
Curr Drug Targets; 2020; 21(3):213-227. PubMed ID: 31433756
[TBL] [Abstract][Full Text] [Related]
2. Pro-Inflammatory Cytokines: New Potential Therapeutic Targets for Obesity-Related Bone Disorders.
Wang T; He C; Yu X
Curr Drug Targets; 2017; 18(14):1664-1675. PubMed ID: 28056748
[TBL] [Abstract][Full Text] [Related]
3. Pro-inflammatory Cytokines: Cellular and Molecular Drug Targets for Glucocorticoid-induced-osteoporosis via Osteocyte.
Wang T; Yu X; He C
Curr Drug Targets; 2019; 20(1):1-15. PubMed ID: 29618305
[TBL] [Abstract][Full Text] [Related]
4. Cytokine-mediated bone destruction in rheumatoid arthritis.
Jung SM; Kim KW; Yang CW; Park SH; Ju JH
J Immunol Res; 2014; 2014():263625. PubMed ID: 25295284
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-17A Interweaves the Skeletal and Immune Systems.
Tang M; Lu L; Yu X
Front Immunol; 2020; 11():625034. PubMed ID: 33613566
[TBL] [Abstract][Full Text] [Related]
6. Taking a toll on the bones: regulation of bone metabolism by innate immune regulators.
Bar-Shavit Z
Autoimmunity; 2008 Apr; 41(3):195-203. PubMed ID: 18365832
[TBL] [Abstract][Full Text] [Related]
7. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis.
Romas E; Gillespie MT; Martin TJ
Bone; 2002 Feb; 30(2):340-6. PubMed ID: 11856640
[TBL] [Abstract][Full Text] [Related]
8. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide and bone.
Evans DM; Ralston SH
J Bone Miner Res; 1996 Mar; 11(3):300-5. PubMed ID: 8852940
[TBL] [Abstract][Full Text] [Related]
10. Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention.
Karmakar S; Kay J; Gravallese EM
Rheum Dis Clin North Am; 2010 May; 36(2):385-404. PubMed ID: 20510240
[TBL] [Abstract][Full Text] [Related]
11. Gene Modification of Transforming Growth Factor β (TGF-β) and Interleukin 10 (IL-10) in Suppressing Mt Sonicate Induced Osteoclast Formation and Bone Absorption.
Yi L; Li Z; Jiang H; Cao Z; Liu J; Zhang X
Med Sci Monit; 2018 Jul; 24():5200-5207. PubMed ID: 30050032
[TBL] [Abstract][Full Text] [Related]
12. [Regulation of bone by IL-17-producing T cells].
Okamoto K
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(5):361-366. PubMed ID: 29238018
[TBL] [Abstract][Full Text] [Related]
13. Frontline Science: Human bone cells as a source of IL-27 under inflammatory conditions: role of TLRs and cytokines.
Larousserie F; Bsiri L; Dumaine V; Dietrich C; Audebourg A; Radenen-Bussière B; Anract P; Vacher-Lavenu MC; Devergne O
J Leukoc Biol; 2017 Jun; 101(6):1289-1300. PubMed ID: 27677834
[TBL] [Abstract][Full Text] [Related]
14. Immune regulation of osteoclast function in postmenopausal osteoporosis: a critical interdisciplinary perspective.
Zhao R
Int J Med Sci; 2012; 9(9):825-32. PubMed ID: 23136547
[TBL] [Abstract][Full Text] [Related]
15. Ablation of p38α MAPK Signaling in Osteoblast Lineage Cells Protects Mice From Bone Loss Induced by Estrogen Deficiency.
Thouverey C; Caverzasio J
Endocrinology; 2015 Dec; 156(12):4377-87. PubMed ID: 26441240
[TBL] [Abstract][Full Text] [Related]
16. Roles of TNF-α, GSK-3β and RANKL in the occurrence and development of diabetic osteoporosis.
Qi J; Hu KS; Yang HL
Int J Clin Exp Pathol; 2015; 8(10):11995-2004. PubMed ID: 26722385
[TBL] [Abstract][Full Text] [Related]
17. Enhanced immunoprotective effects by anti-IL-17 antibody translates to improved skeletal parameters under estrogen deficiency compared with anti-RANKL and anti-TNF-α antibodies.
Tyagi AM; Mansoori MN; Srivastava K; Khan MP; Kureel J; Dixit M; Shukla P; Trivedi R; Chattopadhyay N; Singh D
J Bone Miner Res; 2014 Sep; 29(9):1981-92. PubMed ID: 24677326
[TBL] [Abstract][Full Text] [Related]
18. Osteoporosis: interferon-gamma-mediated bone remodeling in osteoimmunology.
Li S; Liu G; Hu S
Front Immunol; 2024; 15():1396122. PubMed ID: 38817601
[TBL] [Abstract][Full Text] [Related]
19. Interferon-Gamma-Mediated Osteoimmunology.
Tang M; Tian L; Luo G; Yu X
Front Immunol; 2018; 9():1508. PubMed ID: 30008722
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-alpha and interleukin-1beta increase the Fas-mediated apoptosis of human osteoblasts.
Tsuboi M; Kawakami A; Nakashima T; Matsuoka N; Urayama S; Kawabe Y; Fujiyama K; Kiriyama T; Aoyagi T; Maeda K; Eguchi K
J Lab Clin Med; 1999 Sep; 134(3):222-31. PubMed ID: 10482306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
